
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
It is important that health-care providers who are knowledgeable and concerned about the health of children participate on their behalf should another such terrorist attack occur in the United States. What can you, as a pediatrician, do to be certain that children are not left out?






